Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.105 USD | +4.54% | +4.44% | +20.99% |
01:18pm | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
05-09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.99% | 715M | |
+7.00% | 111B | |
+10.52% | 106B | |
-12.42% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.99% | 16.81B | |
+38.75% | 12.54B | |
-24.80% | 8.09B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Wave Life Sciences : SVB Leerink Adjusts WAVE Life Sciences' Price Target to $7 from $10, Keeps Market Perform Rating